Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationEBIATMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsReceivables - NetShares IssuedShares OutstandingShares OutstandingWages, Salaries and Other
Ratios

Traws Pharma (TRAW) Accumulated Depreciation & Amortization (2016 - 2025)

Traws Pharma (TRAW) has disclosed Accumulated Depreciation & Amortization for 14 consecutive years, with $3000.0 as the latest value for Q4 2025.

  • For Q4 2025, Accumulated Depreciation & Amortization changed N/A year-over-year to $3000.0; the TTM value through Dec 2025 reached $3000.0, changed N/A, while the annual FY2025 figure was $3000.0, N/A changed from the prior year.
  • Accumulated Depreciation & Amortization hit $3000.0 in Q4 2025 for Traws Pharma, down from $72000.0 in the prior quarter.
  • Across five years, Accumulated Depreciation & Amortization topped out at $72000.0 in Q3 2024 and bottomed at $3000.0 in Q4 2025.
  • Average Accumulated Depreciation & Amortization over 5 years is $43812.5, with a median of $44000.0 recorded in 2022.
  • On a YoY basis, Accumulated Depreciation & Amortization climbed as much as 77.78% in 2021 and fell as far as 99.06% in 2021.
  • Traws Pharma's Accumulated Depreciation & Amortization stood at $32000.0 in 2021, then soared by 43.75% to $46000.0 in 2022, then skyrocketed by 34.78% to $62000.0 in 2023, then increased by 16.13% to $72000.0 in 2024, then plummeted by 95.83% to $3000.0 in 2025.
  • According to Business Quant data, Accumulated Depreciation & Amortization over the past three periods came in at $3000.0, $72000.0, and $70000.0 for Q4 2025, Q3 2024, and Q2 2024 respectively.